Neurodevelopmental Disorders (NDD)CREADEVNCT07803146
Creative Processes and Children With a Neurodeveloppement Disorder
An observational study of Neurodevelopmental Disorders (NDD), run by Assistance Publique - Hôpitaux de Paris at 1 site in France.
Trial summary
Neurodevelopmental disorders (NDDs) are associated with diverse cognitive profiles, including creative abilities that remain poorly documented. Studying creative processes in children helps to deepen our understanding of cognitive and developmental functioning in NDDs and to explore the development of more appropriate… Read more about this study
- Who is it for?
- Ages 6 to 12 years
- Conditions the study is for
- Neurodevelopmental Disorders (NDD)
- How many people
- 212 participants
- Where
- 1 siteFrance
- Study dates
- 15 Sep 2026to 15 Sep 2031
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 6 to 12 years
- All sexes
- No healthy volunteers
- Child
Study population: Children aged between 6 and 12 with a neurodevelopmental disorder, who are hospitalised in the ward.
Who may be able to join
- Children aged 6 to 12 years
- Prior inclusion in one of the existing clinical cohorts
- No objection from those with parental authority
- Consent from the participant, who must have read and understood the information leaflet
- No acute malnutrition or acute medical condition
Who cannot join
- Acute malnutrition or ongoing parenteral nutrition
- Acute intercurrent medical condition
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site
Hôpital Robert Debré
Paris, 75019
Mylène FEFEU, MD, 0140032002 ext. 0033, mylene.fefeu@aphp.fr
About this study
Official title: Study of Creative Processes in Children Aged 6 to 12 With a Neurodeveloppement Disorder
Neurodevelopmental disorders (NDDs) are associated with diverse cognitive profiles, including creative abilities that remain poorly documented. Studying creative processes in children helps to deepen our understanding of cognitive and developmental functioning in NDDs and to explore the development of more appropriate and inclusive assessment and support tools
Read the detailed description
Once consent has been obtained, the assessments are carried out within the Child and Adolescent Psychiatry Department at Robert-Debré Hospital.
The verbal and figural tests will be administered by a neuropsychologist or a trained doctor, following a standardised procedure:
- AUT (verbal)
- Ocsai-D
- LEGO building task
- Paediatric ICAA parent questionnaire
- Conditions
- Neurodevelopmental Disorders (NDD)
- Keywords
- psychiatry, pediatry, creativity
- Medical subject headings
- Neurodevelopmental Disorders
What is being measured
The primary outcome is the main question the study is designed to answer.
Composite creative Score
To characterise performance in creativity and divergent thinking among patients with TND, using a range of stimuli
Measured: 5 years
Secondary outcomes (1)
paediatric adaptation of the Inventory of Creative Activities and Achievement (ICAA).
At day 1
Measured: A parent-completed questionnaire on children's creative achievements
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Sep 2026
- Study start15 Sep 2026 (estimated)
- Primary completion15 Sep 2031 (estimated)
- Study completion15 Sep 2031 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Neurodevelopmental Disorders (NDD)Studies of the same condition, open and under way.
- More trials run by Assistance Publique - Hôpitaux de ParisThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 212 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Sponsor type
- University, hospital or other
- Collaborators
- Paris Brain Institute (ICM)
- Responsible party
- Sponsor
- Investigators
- Mylène FEFEU, MD, Principal investigator, Assistance Publique - Hôpitaux de Paris
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07803146
- Sponsor's protocol ID
- APHP260156
- Other IDs
- 2026-A00346-45
- Acronym
- CREADEV
- Status last verified
- Sep 2026
- First submitted
- 28 Aug 2026
- Last updated
- 3 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 3 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Study of Creative Processes in Children Aged 6 to 12 With a Neurodeveloppement Disorder
- ClinicalTrials.gov ID
- NCT07803146
- Acronym / sponsor ID
- CREADEV / APHP260156
- Conditions
- Neurodevelopmental Disorders (NDD)
- Keywords
- psychiatry, pediatry, creativity
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 212 participants (estimated)
- Lead sponsor
- Assistance Publique - Hôpitaux de ParisUniversity, hospital or other
- Collaborators
- Paris Brain Institute (ICM)
- Study start
- 15 Sep 2026 (estimated)
- Primary completion
- 15 Sep 2031 (estimated)
- Study completion
- 15 Sep 2031 (estimated)
- First posted
- 3 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Neurodevelopmental disorders (NDDs) are associated with diverse cognitive profiles, including creative abilities that remain poorly documented. Studying creative processes in children helps to deepen our understanding of cognitive and developmental functioning in NDDs and to explore the development of more appropriate and inclusive assessment and support tools
Detailed description
Once consent has been obtained, the assessments are carried out within the Child and Adolescent Psychiatry Department at Robert-Debré Hospital.
The verbal and figural tests will be administered by a neuropsychologist or a trained doctor, following a standardised procedure:
- AUT (verbal)
- Ocsai-D
- LEGO building task
- Paediatric ICAA parent questionnaire
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 6 to 12 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
- Study population
- Children aged between 6 and 12 with a neurodevelopmental disorder, who are hospitalised in the ward.
Key inclusion criteria (5 listed)
- Children aged 6 to 12 years
- Prior inclusion in one of the existing clinical cohorts
- No objection from those with parental authority
- Consent from the participant, who must have read and understood the information leaflet
- No acute malnutrition or acute medical condition
Key exclusion criteria (2 listed)
- Acute malnutrition or ongoing parenteral nutrition
- Acute intercurrent medical condition
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Composite creative Score
Time frame: 5 years
To characterise performance in creativity and divergent thinking among patients with TND, using a range of stimuli
1 secondary outcome
paediatric adaptation of the Inventory of Creative Activities and Achievement (ICAA).
Time frame: A parent-completed questionnaire on children's creative achievements
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Sep 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Neurodevelopmental Disorders (NDD)
Recruiting
A Comparison of Group Cognitive Behavioural Therapy (CBT) and Structured Activity Group for Adults With Attention Deficit Hyperactivity Disorder (ADHD)
ADHD
Not yet recruiting
Efficacy of a Group-based and Digital Parent Sleep Intervention in HK Preschoolers With NDDs
Neurodevelopmental Disorders (NDD), Preschool Child Development
Recruiting
Characterization of the Natural History of Microduplication Syndrome 7q11.23
7q11.23 Microduplication Syndrome (7DUP), Autism Spectrum Disorder (ASD)
RecruitingObservational study
SLC6A1-NDD Prospective Longitudinal Natural History Study
SLC6A1 Neurodevelopmental Disorder (NDD), Developmental and Epileptic Encephalopathies (DEE)
RecruitingPhase 3
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
GRIN-related Neurodevelopmental Disorder
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Mylène FEFEU, MD principal investigator
Assistance Publique - Hôpitaux de Paris
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Neurodevelopmental Disorders (NDD), run by Assistance Publique - Hôpitaux de Paris at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 3 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Mylène FEFEU, MD (0140032002 ext. 0033, mylene.fefeu@aphp.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Composite creative Score (time frame: 5 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Sep 2026.